Fig. 1 · Structure
Documents & Downloads
Mioflazine (di(hydrochloride) hydrate)
Nucleoside Transport Inhibitor
Mioflazine dihydrochloride hydrate is a nucleoside transport inhibitor that exhibits sleep-improving properties. It has been shown to enhance the mechanical function of the left ventricle and significantly improves cardiac recovery following global ischemic events. Additionally, Mioflazine dihydrochloride hydrate reduces mitochondrial calcium levels in guinea pig models, making it a useful tool for research in cardiac physiology and potential therapeutic interventions for sleep disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 79467-24-6 |
| Applications | Nucleoside Transport Inhibitor |
| Formula | C29H34Cl4F2N4O3 |
| Molecular Weight | 666.41 |
| SMILES | O=C(C1N(CCCC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)CCN(C1)CC(NC4=C(Cl)C=CC=C4Cl)=O)N.Cl.Cl.O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.